THE WOODLANDS, Texas, Aug. 2, 2021 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced second quarter 2021 results.
Second quarter 2021 revenue was $102 million, a sequential increase of 32% over the first quarter of 2021 reflecting improvements by all business segments, including the seasonal peak in Northern Europe chemicals sales. Net loss before discontinued operations was $6.7 million, inclusive of $4.7 million of non-recurring charges and expenses. This compares to a net loss before discontinued operations of $11.9 million in the first quarter, inclusive of $6.6 million of non-recurring charges and expenses. Net loss per share from continuing operations in the second quarter was $0.05. Excluding the non-recurring charges and expenses, the net loss per share from continuing operations was $0.02. Adjusted EBITDA, excluding non-recurring charges, was $13.0 million, which includes a $1.6 million benefit from the increase in TETRA's equity ownership in CSI Compressco LP and Standard Lithium, where we own approximately 10.9% and 1.1%, respectively. Second quarter adjusted EBITDA was up 44% from the first quarter of 2021 reflecting stronger operational performance from both business segments. Cash flow from operating activities was $1.8 million in the second quarter of 2021 and compared to $5.8 million in the first quarter of 2021, while adjusted free cash flow from continuing operations was a use of cash of $4.5 million reflecting a buildup in working capital from the higher activity levels towards the end of the second quarter. This compares to $5.4 million of adjusted free cash flow from continuing operations in the first quarter of 2021.
Brady Murphy, TETRA's Chief Executive Officer, stated, "We achieved good overall revenue and EBITDA progression from the first quarter, and even more so as the quarter progressed, and with some great wins and key milestones in all of our business segments, I am very encouraged with the outlook going forward. By early June we saw meaningful increase in demand for international and Gulf of Mexico Completion Fluids, which is consistent with what we believe to be the start of strong, multi-year international and offshore recovery. We exited the quarter with June being our highest revenue and Adjusted EBITDA month since March 2020 reflecting sequential improvements in all of our business groups. Completion Fluids and Products Adjusted EBITDA margin of 27.7% was an improvement of 400 basis points from the first quarter of 2021. Although faced with some inflationary headwinds in our Water and Flowback business ahead of our ability to get broad based price increases, the third quarter EBITDA and related margins are expected to benefit from two newly awarded recycling projects, a fully deployed SandstormTM project in Argentina and continued improvement and alignment of service pricing. Going into the second half of the year, we expect to see a continued recovery in our North American onshore business with higher prices plus continued stronger activity in our international fluids business with the potential for strong market recovery in all of our segments heading into 2022."
"The second quarter, and also more recently in July, we received a lot of positive news for our oil and gas related business as well as our low carbon energy opportunities. In July we completed our first international TETRA CS Neptune® fluids job in the North Sea, which also was our first ever high-density monovalent operation. While the revenue from this project was considerably smaller than our typical TETRA CS Neptune® fluids projects in the Gulf of Mexico, it reflects acceptance of this proprietary technology into new markets. We were awarded a three-year completion fluids and services contract with one of the most active deepwater super major operators in the Gulf of Mexico (GoM) that represents a significant market share increase for this customer and for our GoM operations. We have also received a multi-year major completion fluids award through partnering with a major integrated service company for deepwater work in Brazil. We are expecting our international and offshore fluids sales to increase materially in the second half of the year from the first half due to major project awards and overall increased customer activity. With the ongoing growth and success of our Northern European industrial chemicals business, we are proceeding with a planned expansion for our Kokkola calcium chloride plant in Finland to increase capacity by over 25% by mid-2022.
"Each of our low carbon energy business initiatives continues to advance at an accelerated pace. Following diligence and successful CO2 mineralization to design specifications in a San Antonio SkyCycle pilot plant, we have agreed to make a $5 million investment in CarbonFree in the form of a convertible note. This will allow us to participate in the equity upside as CarbonFree continues to make progress in commercializing its SkyCycle proprietary technology and we continue to advance our long term business relationship. Our PureFlowTM high purity zinc bromide has been qualified by three energy storage manufacturers, and we have received our first commercial purchase order well ahead of our year end expectations. We expect that this will be the first of many opportunities for TETRA to expand our PureFlow sales into the energy storage markets. In regard to lithium activities, Standard Lithium announced in the second quarter that they launched an engineering feasibility study to extract lithium from the brine, which would also include bromine, underlying the TETRA Arkansas leases as part of the 2017 agreement between Standard Lithium and TETRA. According to Standard Lithium, the results of this study are expected to be completed in the third quarter of 2021. As previously announced by Standard Lithium, this acreage has 890,000 tons of LCE equivalent at the inferred resource category. As we announced earlier today, we completed a preliminary exploratory study of the bromine and lithium in our Arkansas leases that includes the leases outside of the Standard Lithium agreement. The study indicates a rich brine concentration for both lithium and bromine and supports our actions to further evaluate a full economic feasibility of these assets. Finally, we have executed a memorandum of understanding to work with Anson Resources, an Australian publicly traded minerals company, to explore a business relationship for lithium and bromine extraction from their Paradox Basin Brine Project in southern Utah. The collaboration will include, among other things, the potential off-take agreement of bromine to meet our growing demands for both oil and gas and energy storage, potential licensing of TETRA's patented bromine derivative manufacturing process, as well as operational management of the plant(s).
"We have reduced our term loan by $36.3 million from $220.5 million as of September 30, 2020, to $184.2 million as of June 30, 2021 and reduced it by another $8.2 million in July. This will save us approximately $3.2 million per year, on an annualized basis, in interest expense. In July, we amended our Asset Based Loan ("ABL") extending the maturity to May 2025 and increased our availability for our ABL by approximately $9.4 million. With this amendment, we do not have any maturities until May 2025 other than our requirement to offer to prepay a percentage of excess cash flow following the conclusion of each calendar year. During the first half of 2021, we have recorded mark to market gains of $5.6 million on our equity holdings of CSI Compressco LP and Standard Lithium. As of July 30, 2021, the market value of these investments was $17.8 million, with no restrictions on our ability to monetize these investments. Additionally, in July we received an expected payment of $548,000 from our sale of our controlling interest in CSI Compressco."
This press release includes the following financial measures that are not presented in accordance with generally accepted accounting principles in the United States ("GAAP"): Adjusted earnings per share from continuing operations, Adjusted EBITDA, and Adjusted EBITDA Margin (Adjusted EBITDA as a percent of revenue) on consolidated and segment basis, Adjusted income/(loss) before tax, adjusted free cash flow from continuing operations, and net debt. Please see Schedules E through H for reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures.
Second Quarter Results and Highlights
A summary of key financial metrics for the second quarter are as follows:
Second Quarter 2021 Results |
|||||||||||
Three Months Ended |
|||||||||||
June 30, 2021 |
March 31, 2021 |
June 30, 2020 |
|||||||||
(In Thousands, Except per Share Amounts) |
|||||||||||
Revenue |
$ |
102,326 |
$ |
77,324 |
$ |
96,070 |
|||||
Loss before discontinued operations |
(6,654) |
(11,943) |
(13,179) |
||||||||
Adjusted EBITDA before discontinued operations |
12,967 |
8,981 |
8,941 |
||||||||
GAAP EPS from continuing operations |
(0.05) |
(0.10) |
(0.11) |
||||||||
Adjusted EPS from continuing operations |
(0.02) |
(0.04) |
(0.06) |
||||||||
GAAP net cash provided by operating activities |
1,788 |
5,819 |
38,211 |
||||||||
Adjusted free cash flow from continuing operations |
$ |
(4,450) |
$ |
5,369 |
$ |
31,350 |
Completion Fluids & Products second quarter of 2021 revenue of $64.6 million increased 39% from the first quarter of 2021 driven by the seasonal increase for our Northern Europe industrial chemicals business and stronger offshore completion fluid sales. Completion Fluids & Products income before taxes was $16.4 million in the second quarter (25.4% of revenue) compared to $9.0 million (19.4% of revenue) in the first quarter of 2021. Adjusted EBITDA of $17.9 million increased $6.8 million sequentially. Second quarter Adjusted EBITDA included $1.5 million favorable mark to market adjustment from TETRA's investment in Standard Lithium. TETRA's value of the 1.6 million shares that we own in Standard Lithium was $9.7 million as of July 31, 2021.
Water & Flowback Services revenue was $37.7 million in the second quarter of 2021, an increase of 22% from the first quarter of 2021, and loss before taxes was $5.0 million. Adjusted EBITDA of $2.0 million (5.3% of revenue) increased 123% sequentially as we saw a rebound in Water Management and Flowback testing from the first quarter that was negatively impacted by winter storms.
Free Cash Flow and Balance Sheet
Cash from operating activities was $1.8 million in the second quarter while adjusted free cash flow from continuing operations was a use of cash of $4.5 million. Liquidity at the end of second quarter was $82.0 million. Liquidity is defined as unrestricted cash plus availability under the revolving credit facility. At the end of the second quarter unrestricted cash was $50.3 million and availability under our credit facility was $31.7 million. Debt was $171.8 million before the $8.2 million paydown in July, while net debt was $121.4 million.
Non-recurring Charges and Expenses Items
Non-recurring charges and expenses are reflected on Schedule E and include $1.3 million of cumulative adjustments to long-term incentives and appreciation right expenses, $0.7 million of restructuring and transaction expenses, and $2.7 million of stock warrant fair value adjustment expense.
Conference Call
TETRA will host a conference call to discuss these results tomorrow, August 3, 2021, at 10:30 a.m. Eastern Time. The phone number for the call is 1-888-347-5303. The conference call will also be available by live audio webcast and may be accessed through the Company's investor relations website at http://ir.tetratec.com/events-and-webcasts. A replay of the conference call will be available at 1-877-344-7529 conference number 10158935, for one week following the conference call and the archived webcast will be available through the Company's website for thirty days following the conference call.
Investor Contact
For further information: Elijio Serrano, CFO, TETRA Technologies, Inc., The Woodlands, Texas, Phone: 281.367.1983, www.tetratec.com
Financial Statements, Schedules and Non-GAAP Reconciliation Schedules (Unaudited)
Schedule A: Consolidated Income Statement
Schedule B: Condensed Consolidated Balance Sheet
Schedule C: Consolidated Statements of Cash Flows
Schedule D: Statement Regarding Use of Non-GAAP Financial Measures
Schedule E: Non-GAAP Reconciliation of Adjusted Income (Loss) From Continuing Operations
Schedule F: Non-GAAP Reconciliation of Adjusted EBITDA
Schedule G: Non-GAAP Reconciliation of Net Debt
Schedule H: Non-GAAP Reconciliation to Adjusted Free Cash Flow From Continuing Operations
Company Overview and Forward-Looking Statements
TETRA Technologies, Inc. is a geographically diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, and production well testing. TETRA owns an 10.9% equity interest in CSI Compressco LP (NASDAQ: CCLP) and approximately 1.1% equity interest in Standard Lithium (NYSE: SLI).
Cautionary Statement Regarding Forward Looking Statements
This news release includes certain statements that are deemed to be forward-looking statements. Generally, the use of words such as "may," "see," "expectation," "expect," "intend," "estimate," "projects," "anticipate," "believe," "assume," "could," "should," "plans," "targets" or similar expressions that convey the uncertainty of future events, activities, expectations or outcomes identify forward-looking statements that the Company intends to be included within the safe harbor protections provided by the federal securities laws. These forward-looking statements include statements concerning economic and operating conditions that are outside of our control, including statements concerning the anticipated recovery of the oil and gas industry; curtailments in production and completion activities related to extreme winter weather; potential revenue associated with prospective energy storage projects or our pending carbon capture partnership; projections concerning the Company's business activities, financial guidance, estimated earnings, earnings per share, and statements regarding the Company's beliefs, expectations, plans, goals, future events and performance, and other statements that are not purely historical. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. Such statements are subject to a number of risks and uncertainties, many of which are beyond the control of the Company. Investors are cautioned that any such statements are not guarantees of future performances or results and that actual results or developments may differ materially from those projected in the forward-looking statements. Some of the factors that could affect actual results are described in the section titled "Risk Factors" contained in the Company's Annual Reports on Form 10-K, as well as other risks identified from time to time in its reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission.
Schedule A: Consolidated Income Statement (Unaudited) |
|||||||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||||||
June 30, |
March 31, |
June 30, |
June 30, |
June 30, |
|||||||||||||||
(In Thousands, Except per Share Amounts) |
|||||||||||||||||||
Revenues |
$ |
102,326 |
$ |
77,324 |
$ |
96,070 |
$ |
179,650 |
$ |
228,773 |
|||||||||
Cost of sales, services, and rentals |
77,208 |
60,614 |
70,607 |
137,822 |
164,722 |
||||||||||||||
Depreciation, amortization, and accretion |
8,236 |
8,951 |
9,726 |
17,187 |
19,277 |
||||||||||||||
Impairments and other charges |
449 |
— |
— |
449 |
— |
||||||||||||||
Insurance recoveries |
— |
(110) |
(74) |
(110) |
(74) |
||||||||||||||
Total cost of revenues |
85,893 |
69,455 |
80,259 |
155,348 |
183,925 |
||||||||||||||
Gross profit |
16,433 |
7,869 |
15,811 |
24,302 |
44,848 |
||||||||||||||
General and administrative expense |
17,351 |
20,012 |
23,862 |
37,363 |
44,210 |
||||||||||||||
Interest expense, net |
3,886 |
4,404 |
4,604 |
8,290 |
9,896 |
||||||||||||||
Warrants fair value adjustment expense (income) |
2,698 |
323 |
11 |
3,021 |
(327) |
||||||||||||||
Other income, net |
(2,232) |
(5,095) |
(541) |
(7,327) |
(520) |
||||||||||||||
Loss before taxes and discontinued operations |
(5,270) |
(11,775) |
(12,125) |
(17,045) |
(8,411) |
||||||||||||||
Provision for income taxes |
1,384 |
168 |
1,054 |
1,552 |
1,776 |
||||||||||||||
Loss before discontinued operations |
(6,654) |
(11,943) |
(13,179) |
(18,597) |
(10,187) |
||||||||||||||
Discontinued operations: |
|||||||||||||||||||
Income (loss) from discontinued operations, net of taxes |
(126) |
120,990 |
(23,788) |
120,864 |
(37,156) |
||||||||||||||
Net income (loss) |
(6,780) |
109,047 |
(36,967) |
102,267 |
(47,343) |
||||||||||||||
Less: (income) loss attributable to noncontrolling interest(1) |
27 |
(333) |
15,712 |
(306) |
24,537 |
||||||||||||||
Net income (loss) attributable to TETRA stockholders |
$ |
(6,753) |
$ |
108,714 |
$ |
(21,255) |
$ |
101,961 |
$ |
(22,806) |
|||||||||
Basic and diluted per share information: |
|||||||||||||||||||
Loss from continuing operations |
$ |
(0.05) |
$ |
(0.10) |
$ |
(0.11) |
$ |
(0.15) |
$ |
(0.08) |
|||||||||
Income (loss) from discontinued operations |
$ |
0.00 |
$ |
0.96 |
$ |
(0.06) |
$ |
0.96 |
$ |
(0.10) |
|||||||||
Net income (loss) attributable to TETRA stockholders |
$ |
(0.05) |
$ |
0.86 |
$ |
(0.17) |
$ |
0.81 |
$ |
(0.18) |
|||||||||
Weighted average shares outstanding |
126,583 |
126,149 |
125,886 |
126,365 |
125,736 |
(1) |
(Income) loss attributable to noncontrolling interest includes zero, $333 income and $15,781 loss for the three-month periods ended June 30, 2021, March 31, 2021 and June 30, 2020, respectively, and $333 income and $24,615 loss for the six-month periods ended June 30, 2021 and 2020, respectively, related to discontinued operations. |
Schedule B: Condensed Consolidated Balance Sheet (Unaudited) |
|||||
June 30, |
December 31, |
||||
(In Thousands) |
|||||
(Unaudited) |
|||||
ASSETS |
|||||
Current assets: |
|||||
Cash and cash equivalents |
$ |
50,314 |
$ |
67,252 |
|
Restricted cash |
65 |
65 |
|||
Trade accounts receivable |
79,467 |
64,078 |
|||
Inventories |
70,071 |
76,658 |
|||
Assets of discontinued operations |
— |
710,006 |
|||
Prepaid expenses and other current assets |
15,881 |
13,487 |
|||
Total current assets |
215,798 |
931,546 |
|||
Property, plant, and equipment, net |
91,423 |
96,856 |
|||
Patents, trademarks and other intangible assets, net |
39,237 |
41,487 |
|||
Deferred tax assets, net |
44 |
52 |
|||
Operating lease right-of-use assets |
39,517 |
43,448 |
|||
Investments |
16,221 |
2,675 |
|||
Other assets |
14,569 |
16,775 |
|||
Total long-term assets |
201,011 |
201,293 |
|||
Total assets |
$ |
416,809 |
$ |
1,132,839 |
|
LIABILITIES AND EQUITY |
|||||
Current liabilities: |
|||||
Trade accounts payable |
$ |
38,868 |
$ |
22,573 |
|
Unearned income |
3,019 |
2,675 |
|||
Accrued liabilities and other |
44,069 |
38,791 |
|||
Liabilities of discontinued operations |
1,601 |
734,039 |
|||
Current portion of long-term debt |
8,157 |
— |
|||
Total current liabilities |
95,714 |
798,078 |
|||
Long-term debt, net |
163,603 |
199,894 |
|||
Deferred income taxes |
1,939 |
1,942 |
|||
Asset retirement obligations |
12,699 |
12,484 |
|||
Warrants liability |
3,219 |
198 |
|||
Operating lease liabilities |
33,786 |
37,569 |
|||
Other liabilities |
6,792 |
11,612 |
|||
Total long-term liabilities |
222,038 |
263,699 |
|||
Commitments and contingencies |
|||||
TETRA stockholders' equity |
100,158 |
(9,640) |
|||
Noncontrolling interests |
(1,101) |
80,702 |
|||
Total equity |
99,057 |
71,062 |
|||
Total liabilities and equity |
$ |
416,809 |
$ |
1,132,839 |
Schedule C: Consolidated Statements of Cash Flows (Unaudited) |
|||||||
Six Months Ended |
|||||||
2021 |
2020 |
||||||
(In Thousands) |
|||||||
Operating activities: |
|||||||
Net income (loss) |
$ |
102,267 |
$ |
(47,343) |
|||
Reconciliation of net income (loss) to net cash provided by operating activities: |
|||||||
Depreciation, amortization, and accretion |
17,215 |
59,302 |
|||||
Gain on GP Sale |
(120,574) |
— |
|||||
Impairment and other charges |
449 |
14,348 |
|||||
Gain on retained CSI Compressco units and Standard Lithium shares |
(5,613) |
(183) |
|||||
Equity-based compensation expense |
2,554 |
2,896 |
|||||
Amortization and expense of financing costs and deferred financing gains |
1,429 |
2,755 |
|||||
Debt-related expenses |
— |
4,754 |
|||||
Warrants fair value adjustment |
3,021 |
(326) |
|||||
Gain on sale of assets |
(275) |
(2,019) |
|||||
Other non-cash charges |
(70) |
5,380 |
|||||
Changes in operating assets and liabilities: |
|||||||
Accounts receivable |
(15,694) |
55,552 |
|||||
Inventories |
5,456 |
10,733 |
|||||
Prepaid expenses and other current assets |
(2,442) |
(3,038) |
|||||
Trade accounts payable and accrued expenses |
21,295 |
(42,853) |
|||||
Other |
(1,411) |
429 |
|||||
Net cash provided by operating activities |
7,607 |
60,387 |
|||||
Investing activities: |
|||||||
Purchases of property, plant, and equipment, net |
(12,489) |
(19,608) |
|||||
Proceeds from sale of CCLP, net of cash divested |
18 |
— |
|||||
Proceeds on sale of property, plant, and equipment |
754 |
5,311 |
|||||
Insurance recoveries associated with damaged equipment |
110 |
591 |
|||||
Other investing activities |
1,156 |
(357) |
|||||
Net cash used in investing activities |
(10,451) |
(14,063) |
|||||
Financing activities: |
|||||||
Proceeds from long-term debt |
— |
338,343 |
|||||
Principal payments on long-term debt |
(29,320) |
(341,364) |
|||||
CSI Compressco distributions |
— |
(620) |
|||||
Tax remittances on equity based compensation |
— |
(341) |
|||||
Debt issuance costs and other financing activities |
(455) |
(2,504) |
|||||
Net cash provided by (used in) financing activities |
(29,775) |
(6,486) |
|||||
Effect of exchange rate changes on cash |
(896) |
(826) |
|||||
(Decrease) increase in cash and cash equivalents |
(33,515) |
39,012 |
|||||
Cash and cash equivalents and restricted cash at beginning of period |
83,894 |
17,768 |
|||||
Cash and cash equivalents at beginning of period associated with discontinued operations |
16,577 |
2,370 |
|||||
Cash and cash equivalents and restricted cash at beginning of period associated with continuing operations |
67,317 |
15,398 |
|||||
Cash and cash equivalents and restricted cash at end of period |
50,379 |
56,780 |
|||||
Cash and cash equivalents at end of period associated with discontinued operations |
— |
6,757 |
|||||
Cash and cash equivalents and restricted cash at end of period associated with continuing operations |
$ |
50,379 |
$ |
50,023 |
Schedule D: Statement Regarding Use of Non-GAAP Financial Measures
In addition to financial results determined in accordance with U.S. GAAP, this press release may include the following non-GAAP financial measures for the Company: net debt; adjusted consolidated and segment income (loss) before taxes, special charges and discontinued operations; adjusted diluted earnings (loss) per share from continuing operations; consolidated and segment adjusted EBITDA; adjusted free cash flow and free cash flow from continuing operations; and segment adjusted EBITDA as a percent of revenue ("Adjusted EBITDA margin"). The following schedules provide reconciliations of these non-GAAP financial measures to their most directly comparable U.S. GAAP measures. The non-GAAP financial measures should be considered in addition to, not as a substitute for, financial measures prepared in accordance with U.S. GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.
Management believes that the exclusion of the special charges from the historical results of operations enables management to evaluate more effectively the Company's operations over the prior periods and to identify operating trends that could be obscured by the excluded items.
Adjusted income (loss) from continuing operations is defined as the Company's income (loss) before noncontrolling interests and discontinued operations, excluding certain special or other charges (or credits), and including noncontrolling interest attributable to continued operations. Adjusted income (loss) from continuing operations is used by management as a supplemental financial measure to assess financial performance, without regard to charges or credits that are considered by management to be outside of its normal operations. Adjusted diluted earnings (loss) per share from continuing operations is defined as the Company's diluted earnings (loss) per share excluding certain special or other charges (or credits), discontinued operations and noncontrolling interest attributable to discontinued operations. Adjusted diluted earnings (loss) per share is used by management as a supplemental financial measure to assess financial performance, without regard to charges or credits that are considered by management to be outside of its normal operations.
Adjusted EBITDA (and Adjusted EBITDA as a percent of revenue) is defined as earnings before interest, taxes, depreciation, amortization, impairments and certain non-cash charges, non-recurring adjustments and discontinued operations. Adjusted EBITDA (and Adjusted EBITDA margin) is used by management as a supplemental financial measure to assess the financial performance of the Company's assets, without regard to financing methods, capital structure or historical cost basis and to assess the Company's ability to incur and service debt and fund capital expenditures. Adjusted free cash flow from continuing operations is defined as cash from operations less discontinued operations EBITDA and discontinued operations capital expenditures, less capital expenditures net of sales proceeds and cost of equipment sold and including cash distributions to TETRA from CSI Compressco LP and cash from other investments. Management uses this supplemental financial measure to:
- assess the Company's ability to retire debt;
- evaluate the capacity of the Company to further invest and grow; and
- to measure the performance of the Company as compared to its peer group.
Adjusted free cash flow from continuing operations do not necessarily imply residual cash flow available for discretionary expenditures, as they exclude cash requirements for debt service or other non-discretionary expenditures that are not deducted.
Net debt is defined as the sum of the carrying value of long-term and short-term debt on its consolidated balance sheet, less cash, excluding restricted cash on the balance sheet. Management views net debt as a measure of TETRA's ability to reduce debt, add to cash balances, pay dividends, repurchase stock, and fund investing and financing activities.
Schedule E: Non-GAAP Reconciliation of Adjusted Income (Loss) From Continuing Operations (Unaudited) |
|||||||||||
Three Months Ended |
|||||||||||
June 30, |
March 31, |
June 30, |
|||||||||
(In Thousands, Except per Share Amounts) |
|||||||||||
Loss before taxes and discontinued operations |
$ |
(5,270) |
$ |
(11,775) |
$ |
(12,125) |
|||||
(Provision) benefit for income taxes |
(1,384) |
(168) |
(1,054) |
||||||||
Noncontrolling interest attributed to continuing operations |
27 |
— |
(69) |
||||||||
Loss from continuing operations |
(6,627) |
(11,943) |
(13,248) |
||||||||
Adjustment to long-term incentives |
627 |
2,897 |
— |
||||||||
Transaction and other expenses |
(345) |
2,550 |
186 |
||||||||
Impairments and other charges |
— |
— |
— |
||||||||
Former CEO stock appreciation right expense |
714 |
509 |
— |
||||||||
Restructuring charges |
1,033 |
340 |
218 |
||||||||
Debt refinancing |
— |
— |
— |
||||||||
Stock warrant fair value adjustment |
2,698 |
323 |
11 |
||||||||
Severance expenses |
— |
— |
1,920 |
||||||||
Bad debt |
— |
— |
2,800 |
||||||||
Adjusted income (loss) from continuing operations |
$ |
(1,900) |
$ |
(5,324) |
$ |
(8,113) |
|||||
Basic and diluted per share information |
|||||||||||
Loss from continuing operations |
$ |
(0.05) |
$ |
(0.10) |
$ |
(0.11) |
|||||
Adjusted income (loss) from continuing operations |
$ |
(0.02) |
$ |
(0.04) |
$ |
(0.06) |
|||||
Diluted weighted average shares outstanding |
126,583 |
126,149 |
125,886 |
Schedule F: Non-GAAP Reconciliation of Adjusted EBITDA (Unaudited) |
||||||||||||||||||||
Three Months Ended June 30, 2021 |
||||||||||||||||||||
Completion |
Water & |
Corporate |
Other and |
Total |
||||||||||||||||
(In Thousands, Except Percents) |
||||||||||||||||||||
Revenues |
$ |
64,607 |
$ |
37,719 |
$ |
— |
$ |
— |
$ |
102,326 |
||||||||||
Net income (loss) before taxes and discontinued operations |
16,427 |
(4,978) |
(9,543) |
(7,176) |
(5,270) |
|||||||||||||||
Adjustment to long-term incentives |
— |
— |
627 |
— |
627 |
|||||||||||||||
Transaction and other expenses |
(391) |
145 |
(99) |
— |
(345) |
|||||||||||||||
Former CEO stock appreciation right expense |
— |
— |
714 |
— |
714 |
|||||||||||||||
Restructuring expenses |
291 |
742 |
— |
— |
1,033 |
|||||||||||||||
Stock warrant fair value adjustment |
— |
— |
— |
2,698 |
2,698 |
|||||||||||||||
Adjusted income (loss) before taxes and discontinued operations |
$ |
16,327 |
$ |
(4,091) |
$ |
(8,301) |
$ |
(4,478) |
$ |
(543) |
||||||||||
Adjusted interest expense, net |
(162) |
3 |
— |
4,044 |
3,885 |
|||||||||||||||
Adjusted depreciation and amortization |
1,701 |
6,087 |
— |
245 |
8,033 |
|||||||||||||||
Equity compensation expense |
— |
— |
1,592 |
— |
1,592 |
|||||||||||||||
Adjusted EBITDA |
$ |
17,866 |
$ |
1,999 |
$ |
(6,709) |
$ |
(189) |
$ |
12,967 |
||||||||||
Adjusted EBITDA as a % of revenue |
27.7 |
% |
5.3 |
% |
12.7 |
% |
||||||||||||||
Three Months Ended March 31, 2021 |
||||||||||||||||||||
Completion |
Water & |
Corporate |
Other and |
Total |
||||||||||||||||
(In Thousands, Except Percents) |
||||||||||||||||||||
Revenues |
$ |
46,522 |
$ |
30,802 |
$ |
— |
$ |
— |
$ |
77,324 |
||||||||||
Net income (loss) before taxes and discontinued operations |
9,010 |
(5,480) |
(13,020) |
(2,285) |
(11,775) |
|||||||||||||||
Adjustment to long-term incentives |
281 |
— |
2,616 |
— |
2,897 |
|||||||||||||||
Transaction and other expenses |
— |
— |
2,550 |
— |
2,550 |
|||||||||||||||
Former CEO stock appreciation right expense |
— |
— |
509 |
— |
509 |
|||||||||||||||
Restructuring and severance expenses |
181 |
— |
160 |
— |
341 |
|||||||||||||||
Stock warrant fair value adjustment |
— |
— |
— |
323 |
323 |
|||||||||||||||
Adjusted income (loss) before taxes and discontinued operations |
$ |
9,472 |
$ |
(5,480) |
$ |
(7,185) |
$ |
(1,962) |
$ |
(5,155) |
||||||||||
Adjusted interest expense, net |
(138) |
(522) |
— |
5,064 |
4,404 |
|||||||||||||||
Adjusted depreciation and amortization |
1,705 |
6,899 |
— |
166 |
8,770 |
|||||||||||||||
Equity compensation expense |
— |
— |
962 |
— |
962 |
|||||||||||||||
Adjusted EBITDA |
$ |
11,039 |
$ |
897 |
$ |
(6,223) |
$ |
3,268 |
$ |
8,981 |
||||||||||
Adjusted EBITDA as a % of revenue |
23.7 |
% |
2.9 |
% |
11.6 |
% |
||||||||||||||
Three Months Ended June 30, 2020 |
||||||||||||||||||||
Completion |
Water & |
Corporate |
Other and |
Total |
||||||||||||||||
(In Thousands, Except Percents) |
||||||||||||||||||||
Revenues |
$ |
71,346 |
$ |
24,724 |
$ |
— |
$ |
— |
$ |
96,070 |
||||||||||
Net income (loss) before taxes and discontinued operations |
13,202 |
(8,418) |
(11,611) |
(5,298) |
(12,125) |
|||||||||||||||
Severance |
569 |
1,016 |
334 |
— |
1,919 |
|||||||||||||||
Transaction and other expenses |
(90) |
— |
276 |
— |
186 |
|||||||||||||||
Restructuring and severance expenses |
31 |
187 |
— |
— |
218 |
|||||||||||||||
Stock warrant fair value adjustment |
— |
— |
— |
11 |
11 |
|||||||||||||||
Allowance for bad debt |
2,800 |
— |
— |
— |
2,800 |
|||||||||||||||
Adjusted income (loss) before taxes and discontinued operations |
16,512 |
(7,215) |
— |
(11,001) |
(5,287) |
(6,991) |
||||||||||||||
Adjusted interest expense, net |
(143) |
(2) |
— |
4,749 |
4,604 |
|||||||||||||||
Adjusted depreciation and amortization |
1,934 |
7,617 |
— |
175 |
9,726 |
|||||||||||||||
Equity compensation expense |
— |
— |
1,602 |
— |
1,602 |
|||||||||||||||
Adjusted EBITDA |
$ |
18,303 |
$ |
400 |
$ |
(9,399) |
$ |
(363) |
$ |
8,941 |
||||||||||
Adjusted EBITDA as a % of revenue |
25.7 |
% |
1.6 |
% |
9.3 |
% |
||||||||||||||
Schedule G: Non-GAAP Reconciliation of TETRA Net Debt (Unaudited) |
|||||||
The following reconciliation of net debt is presented as a supplement to financial results prepared in accordance with GAAP. |
|||||||
June 30, |
December 31, |
||||||
(In Thousands) |
|||||||
Non-restricted cash |
$ |
50,314 |
$ |
67,252 |
|||
Asset-Based Credit Agreement |
— |
— |
|||||
Term Credit Agreement |
$ |
171,760 |
$ |
199,894 |
|||
Net debt |
$ |
121,446 |
$ |
132,642 |
Schedule H: Non-GAAP Reconciliation to Adjusted Free Cash Flow From Continuing Operations (Unaudited) |
|||||||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||||||
June 30, |
March 31, |
June 30, |
June 30, |
June 30, |
|||||||||||||||
(In Thousands) |
|||||||||||||||||||
Cash from operating activities |
$ |
1,788 |
$ |
5,819 |
$ |
38,211 |
$ |
7,607 |
$ |
60,387 |
|||||||||
Discontinued operations operating activities (adjusted EBITDA income (loss)) |
— |
(416) |
4,823 |
(416) |
18,180 |
||||||||||||||
Cash from continued operating activities |
1,788 |
6,235 |
33,388 |
8,023 |
42,207 |
||||||||||||||
Less: Continuing operations capital expenditures |
(6,290) |
(3,220) |
(2,207) |
(9,510) |
(6,689) |
||||||||||||||
Distributions from CSI Compressco LP (1) |
52 |
— |
169 |
52 |
338 |
||||||||||||||
Cash (distributed to partners) received from other investments |
— |
2,354 |
— |
2,354 |
— |
||||||||||||||
Adjusted Free Cash Flow From Continuing Operations |
$ |
(4,450) |
$ |
5,369 |
$ |
31,350 |
$ |
919 |
$ |
35,856 |
|||||||||
(1) |
Following the GP Sale on January 29, 2021, TETRA retained a 10.9% limited partner interest in CCLP. |